Koers Satsuma Pharmaceuticals, Inc.
Aandelen
STSA
US80405P1075
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01-01-17 |
Chief Tech/Sci/R&D Officer | 63 | 01-07-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Director/Board Member | 64 | 08-06-23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01-06-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,51% | 105 mld. | |
+3,22% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,53% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,09% | 14,52 mld. | |
+5,47% | 14,09 mld. | |
+28,85% | 10,99 mld. |